Clinical Trials Browser

Terminated × Interventional × Breast Carcinoma In Situ × Clear all

NCT04570956 2026-01-23

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms

NCT03979508 2025-11-12

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Phase 2 Terminated

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Fibrocystic Breast Disease, Triple Negative Breast Neoplasms

NCT04185311 2023-08-15

Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

Phase 1 Terminated

Breast Carcinoma In Situ, Triple Negative Breast Neoplasms

NCT00002934 2023-06-22

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Phase 2 Terminated

3 enrolled 4 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

NCT00110136 2021-09-29

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

Phase 2 Terminated

9 enrolled 10 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hot Flashes

NCT00112749 2020-07-31

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms, Fatigue

NCT00096369 2019-01-24

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Phase 2 Terminated

8 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Phase 1 Terminated

BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Phase 2 Terminated

45 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01754519 2017-07-07

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Phase 2 Terminated

1 enrolled 4 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00794989 2016-06-03

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Phase NA Terminated

BreastOther neoplasm

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Precancerous Conditions

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Phase 2 Terminated

3 enrolled 4 charts

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating